会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 10. 发明申请
    • SILK NANOSPHERES AND MICROSPHERES AND METHODS OF MAKING SAME
    • 丝绸纳米球和微球及其制备方法
    • WO2011041395A3
    • 2011-08-25
    • PCT/US2010050698
    • 2010-09-29
    • TUFTS COLLEGEWANG XIAOQINKAPLAN DAVID L
    • WANG XIAOQINKAPLAN DAVID L
    • B82B3/00B82B1/00
    • A61K9/5169A61K9/14A61K9/1605A61K9/1647A61K9/5052A61K9/5089A61K9/5192A61K31/352Y10T428/2982
    • The present invention provides for methods of preparing silk nanoparticles and microparticles, methods of encapsulating an active agent into the silk nano- and microparticles and compositions comprising these silk particles. In particular, the silk spheres are prepared from phase separation of silk and polyvinyl alcohol (PVA), without exposure to an organic solvent. The method employs a chemical, PVA, which is an FDA-approved ingredient in drug formulations. Different parameters can be adjusted to control the size and shape of the silk spheres during the fabrication process. The silk particle compositions of the present invention may also encapsulate active agents or chemicals. Such compositions allow the active agents to be controllably and sustainably released to the target organs or tissues. The silk composition entrapping active agents also provides for a long-term storage medium for the active agents so entrapped. The silk nano- and microparticles of the present invention are thus suitable for a variety of biomedical and pharmaceutical applications, such as drug delivery or tissue engineering.
    • 本发明提供制备丝纳米颗粒和微颗粒的方法,将活性剂包封到丝纳米颗粒和微颗粒中的方法以及包含这些丝颗粒的组合物。 特别地,丝球由丝和聚乙烯醇(PVA)的相分离制备,而不暴露于有机溶剂。 该方法使用化学药品PVA,它是药物制剂中FDA批准的成分。 可以调整不同的参数来控制制造过程中丝球的尺寸和形状。 本发明的丝粒组合物也可以包封活性剂或化学品。 这样的组合物允许活性剂可控地并且可持续地释放到靶器官或组织。 捕获活性剂的丝组合物也为这种包埋的活性剂提供了长期存储介质。 因此,本发明的蚕丝纳米颗粒和微米颗粒适用于各种生物医学和药物应用,例如药物递送或组织工程。